Dr. Rafael Gonzalez is a distinguished stem cell expert with over 20 years of experience researching and developing novel therapeutics that have shaped the foundations of Restem Group’s innovative platforms. With a Ph.D. in Biology at the department of Anatomy and Neurobiology from the University of California, Irvine, his work has focused on the immune system’s interactions following spinal cord injuries, providing the groundwork for his advancements in regenerative medicine and translational therapeutics.

Dr. Gonzalez has pioneered groundbreaking stem cell therapies for various diseases and trauma conditions, overseeing multiple investigational new drug (IND) applications utilizing patented stem cell technologies. His expertise extends to immune-based therapies, including those involving natural killer (NK) cells, and his extensive portfolio of scientific publications highlights his leadership in the field. As a cornerstone of Restem Group’s mission, his innovations continue to drive advancements in cell-based therapeutics. He also serves as a scientific advisor for numerous globally recognized organizations, further shaping the regenerative medicine sector.